Intersect ENT | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (27)

View All

Latest Posts

About This Stock More About This Stock
Stock Charts To Watch - Tuesday, June 9
Article By: Harry Boxer
Tuesday, June 9, 2020 8:16 PM EDT
Cemtrex, Inc. exploded on Tuesday, ramping up 1.08, or 53.2%, to 3.11, with an early morning pop to session high at 3.75, on 39 million shares traded. In after-hours, it was up another 21 cents to 3.32. It looks like it wants to go higher.
In this article: AMD, CETX, CLDR, NLTX, WATT, XENT
Read
Biotech Digest – XENT Gets FDA Approval, AGN Announces Acquisition, IONS Licenses Product
Article By: KKD Healthcare Analytics
Tuesday, December 12, 2017 10:26 AM EDT
Intersect ENT Inc. reported the FDA approval for its SINUVA implant, designed to be used for treating recurrent nasal polyps in patients who have had previous ethmoid sinus surgery.
In this article: AGN, MRK, SNY, REGN, RPRX, XENT, IONS, TYHT
Read
Cantor Fitzgerald's Caroline Corner: Cutting-Edge Devices And Diagnostics Deliver Drugs And Profits
Article By: The Life Sciences Report
Tuesday, August 4, 2015 11:47 AM EDT
Caroline Corner of Cantor Fitzgerald follows companies with technologies that can both address dire diseases and reap windfalls for investors. Corner brings important names to investors' attention.
In this article: AGN, AEMD, CERS, D-STEM (DEFUNCT), NVIV, AERI, GKOS Also: RHHBY, ALIM, REGN, ONVO, XENT, MRK
Read
All Posts

Latest Tweets for $XENT

No tweets yet!

PARTNER HEADLINES